Abstract | BACKGROUND: METHODS: Thirty clinical tumor samples of all stages, including 13 samples from patients with Stage 4 disease, were analyzed by quantitative immunoblotting for caspase-8 and STAT-1. The DNA methylation status of putative caspase-8 and STAT-1 regulatory elements were determined by bisulfite-modified sequencing analysis. RESULTS: A significant correlation was observed between caspase-8 and STAT-1 protein levels in Stage 4 NB samples but not in lower stage NB samples. Caspase-8 and STAT-1 protein levels varied widely across all stages of NB and did not correlate with methylation of these genes. CONCLUSIONS: A strong correlation was observed between STAT-1 levels and caspase-8 levels in clinical Stage 4 NB. This suggests that STAT-1 or similar transcription factors, and not methylation, may play a role in controlling caspase-8 levels in this illness. No evidence of such a correlation between caspase-8 and STAT-1 levels was observed in lower clinical stages, suggesting that mechanisms controlling caspase-8 expression in NB vary with clinical stage.
|
Authors | Andrea Muscat, Christine Hawkins, David M Ashley |
Journal | Cancer
(Cancer)
Vol. 107
Issue 4
Pg. 824-31
(Aug 15 2006)
ISSN: 0008-543X [Print] United States |
PMID | 16886176
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- DNA, Neoplasm
- STAT1 Transcription Factor
- CASP8 protein, human
- Caspase 8
- Caspases
|
Topics |
- Caspase 8
- Caspases
(metabolism)
- Cell Line, Tumor
- Child
- Child, Preschool
- DNA Methylation
- DNA, Neoplasm
(genetics)
- Female
- Humans
- Immunoblotting
- Infant
- Infant, Newborn
- Male
- Neoplasm Staging
- Neuroblastoma
(metabolism, pathology)
- Promoter Regions, Genetic
- STAT1 Transcription Factor
(metabolism)
|